The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
for
Peripheral Blood Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 70+
Code: NCT05436418
Phase1, Phase2, Recruiting
The Utilization of Ultrasound to Diagnose Pediatric Elbow Fractures
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
for
B-cell Acute Lymphoblastic Leukemia
Location: New York NY, Philadelphia PA, Cincinnati OH
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1+
Code: NCT07223021
Phase3, Recruiting
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
for
Allogeneic Hematopoietic Cell Transplantation
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04332341
Early_phase1, Recruiting
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
for
High Grade B-Cell Non-Hodgkin's Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05801913
Phase1, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase2, Phase3, Recruiting
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
for
Diffuse Large B-Cell Lymphoma
Location: Des Moines IA, Tacoma WA
Sponsor: AstraZeneca
Sex: All
Age: 65 - 70+
Code: NCT05952024
Phase2, Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
for
Relapsed/Refractory B-cell Malignancies
Location: Chapel Hill NC, Sarasota FL, Cleveland OH, Columbus OH,
Sponsor: Accutar Biotechnology Inc
Sex: All
Age: 18+
Code: NCT05780034
Phase1, Recruiting
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 21+
Code: NCT05054413
Recruiting
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Tampa FL, Madison WI
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06940440
Phase1, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,